These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 32250388)

  • 1. The COVID-19 Pandemic in the US: A Clinical Update.
    Omer SB; Malani P; Del Rio C
    JAMA; 2020 May; 323(18):1767-1768. PubMed ID: 32250388
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn.
    Dong L; Tian J; He S; Zhu C; Wang J; Liu C; Yang J
    JAMA; 2020 May; 323(18):1846-1848. PubMed ID: 32215581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity, specificity, predictive values in serological Covid-19 tests].
    Duca P
    Epidemiol Prev; 2020; 44(2-3):189-190. PubMed ID: 32631019
    [No Abstract]   [Full Text] [Related]  

  • 4. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.
    Patel R; Babady E; Theel ES; Storch GA; Pinsky BA; St George K; Smith TC; Bertuzzi S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32217609
    [No Abstract]   [Full Text] [Related]  

  • 5. The Promise and Peril of Antibody Testing for COVID-19.
    Abbasi J
    JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 7. The explosion of new coronavirus tests that could help to end the pandemic.
    Guglielmi G
    Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum IgA, IgM, and IgG responses in COVID-19.
    Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
    Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
    [No Abstract]   [Full Text] [Related]  

  • 9. Interpreting Diagnostic Tests for SARS-CoV-2.
    Sethuraman N; Jeremiah SS; Ryo A
    JAMA; 2020 Jun; 323(22):2249-2251. PubMed ID: 32374370
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia.
    Zeng H; Xu C; Fan J; Tang Y; Deng Q; Zhang W; Long X
    JAMA; 2020 May; 323(18):1848-1849. PubMed ID: 32215589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 14. The Detection of Novel Coronavirus Antibodies is an Important Supplementary Detection Method for Screening of High-Risk Population.
    Wang D; Jia X; Huang T; Wang H; Li S; Ren T; Nie H; Chen Z; Song C; Zhou Y; Ma W; Shen H
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658430
    [No Abstract]   [Full Text] [Related]  

  • 15. A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    Cai XF; Chen J; Li Hu J; Long QX; Deng HJ; Liu P; Fan K; Liao P; Liu BZ; Wu GC; Chen YK; Li ZJ; Wang K; Zhang XL; Tian WG; Xiang JL; Du HX; Wang J; Hu Y; Tang N; Lin Y; Ren JH; Huang LY; Wei J; Gan CY; Chen YM; Gao QZ; Chen AM; He CL; Wang DX; Hu P; Zhou FC; Huang AL; Wang DQ
    J Infect Dis; 2020 Jun; 222(2):189-193. PubMed ID: 32382737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of point-of-care IgM and IgG test in critically ill patients with SARS-Cov-2.
    Nguyen LS; Laghlam D; De Gonfreville E; Pène F; Rozenberg F; Mira JP
    Crit Care; 2020 Sep; 24(1):573. PubMed ID: 32972451
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 18. How the pandemic might play out in 2021 and beyond.
    Scudellari M
    Nature; 2020 Aug; 584(7819):22-25. PubMed ID: 32760050
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the Quotient® MosaiQ™ COVID-19 antibody microarray for the detection of IgG and IgM antibodies to SARS-CoV-2 virus in humans.
    Martinaud C; Hejl C; Igert A; Bigaillon C; Bonnet C; Mérens A; Wolf A; Foissaud V; Leparc-Goffart I
    J Clin Virol; 2020 Sep; 130():104571. PubMed ID: 32750664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.